Clinical Trials Logo

Spontaneous Pneumothorax clinical trials

View clinical trials related to Spontaneous Pneumothorax.

Filter by:
  • None
  • Page 1

NCT ID: NCT05861037 Completed - Child, Only Clinical Trials

Thoracoscopy for Idiopathic Pneumothorax in Children

PNOPED
Start date: November 1, 2022
Phase:
Study type: Observational

The goal of this retrospective study is to describe the outcomes of spontaneous idiopathic pneumothorax treated by thoracoscopy with pleural abrasion and blebectomy. The main questions it aims to answer are: - are there risk factors leading to pneumothorax recurrence? - are pleural abrasion and blebectomy really diminishing the recurrence of pneumothorax?

NCT ID: NCT04758143 Recruiting - Surgery Clinical Trials

Most Preventable Surgical Option to Reduce Primary Spontaneous Pneumothorax Patients' Postoperative Recurrence: A Prospective Cohort Study

Start date: August 11, 2020
Phase:
Study type: Observational

To investigate the most preventable option to reduce primary spontaneous postoperative recurrence.

NCT ID: NCT03557320 Completed - Clinical trials for Spontaneous Pneumothorax

Environmental Factor and Onset of Spontaneous Pneumothorax

EXPPO
Start date: May 31, 2013
Phase:
Study type: Observational

The study aims to evaluate the association between spontaneous pneumothorax onset and weather parameters.

NCT ID: NCT02916992 Recruiting - Clinical trials for Spontaneous Pneumothorax

Prevalence of Spontaneous Pneumothorax in BHD

Start date: September 2016
Phase: Phase 1
Study type: Interventional

To assess the prevalence of BHD (Birt-Hogg-Dubé syndrome) among patients with spontaneous pneumothorax. Patients who were treated for primary spontaneous pneumothorax in Rijnstate hospital are to be included. Patients will receive a questionnaire. When given consent, the investigators will invite them for a one-time visit to the out-patient clinic. Patients will be asked for a blood sample to determine pathogenic FLCN (folliculin) mutations and a pulmonary CT scan for evaluation of presence of lung cysts.

NCT ID: NCT02573285 Completed - Clinical trials for Spontaneous Pneumothorax

Spontaneous Pneumothorax in Children

Start date: March 10, 2016
Phase: N/A
Study type: Interventional

The objective of this multi-center, non-randomized, prospective pilot study is to examine the rate of successful primary spontaneous pneumothorax (PSP) resolution using the simple aspiration technique. In this study, eligible subjects diagnosed with PSP at eleven participating large children's hospitals (members of the Midwest Pediatric Surgical Clinical Research Consortium) will be enrolled and offered a choice of management with either the simple aspiration protocol or management according to their surgeon's preference, which may include simple aspiration, chest tube placement, or rarely, an operation.

NCT ID: NCT02030795 Completed - Clinical trials for Spontaneous Pneumothorax

Techniques for Lung Deflation With Arndt® Blocker

Start date: January 2014
Phase: Phase 2
Study type: Interventional

The use of wire-guided Arndt® endobronchial blocker does not gain widespread acceptance during video-assisted thoracoscopy (VATS) because it takes longer time to collapse the operative lung especially in patients with chronic obstructive lung disease (COPD). The use of a disconnection technique for deflation of Arndt® blocker had a comparable degree of lung collapse with the use of double-lumen tubes. However, it carries a risk of blood or infected secretions contaminating the dependent lung. We hypothesise that the use bronchial suction of through a barrel part of a 1-mL insulin syringe attached to the suction port of the bronchial blocker would be associated with comparable time to optimum lung collapse with the disconnection technique. After ethical approval, 58 patients with spontaneous pneumothorax scheduled for elective VATS using Arndt blocker® for lung separation will be included in this prospective, randomized, double-blind study. Patients will be randomly assigned to deflate the blocker with either disconnecting the endotracheal tube from the ventilator for 60 s. prior to inflation of the bronchial blocker allowing both lungs to collapse, or attaching -20 cm H2O of suction to the suction port of the blocker through the barrel part of a 1-mL insulin syringe (n = 29 for each group).

NCT ID: NCT01848860 Recruiting - Surgery Clinical Trials

Absorbable Mesh Pleurodesis in Thoracoscopic Treatment of Spontaneous Pneumothorax

Start date: May 2013
Phase: Phase 2/Phase 3
Study type: Interventional

Primary spontaneous pneumothorax usually occurs in young, lean male without underlying lung disease. In most cases, the cause of pneumothorax is rupture of blebs at the apex of the lung. Traditionally, bullectomy with mechanical pleurodesis through thoracotomy is indicated in patients with recurrence or persisted air leakage. In recent years, thoracoscopic bullectomy with pleural abrasion is getting popular, thanks for the advance of endoscopic instruments and technique. The pneumothorax recurrence rate after thoracoscopic surgery is around 10%, which is significantly higher than that of thoracotomy. In addition, the rate of postoperative prolonged air leakage is 5-8%. The possible causes of recurrent pneumothorax and prolonged air leakage are missed bleb surrounding the endoscopic suture line or suboptimal suturing or healing of the thoracoscopic suture. To prevent these complications, a novel method using coverage of the endoscopic suture line by a large absorbable mesh during thoracoscopic surgery was proved to be safe and feasible. Theoretically, the mesh can strengthen the suture line and induce local fibrosis surrounding the suture line, and reduce the rate of recurrent pneumothorax and prolonged air leakage. To prove this hypothesis, the investigators are conducting a prospective randomized trial in National Taiwan University Hospital. The investigators will enroll 204 patients with primary spontaneous pneumothorax who will be randomly assigned to additional mesh pleurodesis (mesh group, 102 patients) or not (control group, 102 patients) after thoracoscopic bullectomy and pleural abrasion. The primary endpoint is to compare the rate of pneumothorax recurrence within one year between the two groups. The secondary endpoints are to compare the safety, efficacy, and long-term pulmonary function between the two groups.